WEDNESDAY, July 3, 2024 -- Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes...
Vous n'êtes pas connecté
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open. Daniel Edmonston, M.D., from the...
WEDNESDAY, July 3, 2024 -- Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes...
FRIDAY, July 5, 2024 -- Acupuncture is associated with improved sleep quality in patients with Parkinson disease, according to a study published...
WEDNESDAY, June 26, 2024 -- The gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study...
TUESDAY, June 25, 2024 -- Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or...
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care,...
Driven by pipeline approvals with diverse mechanisms of action and an influx of newly diagnosed patients, the chronic kidney disease (CKD) market is...
WEDNESDAY, June 26, 2024 -- For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a...
TUESDAY, June 25, 2024 -- For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1...
Insulet (PODD) reports positive findings from the SECURE-T2D pivotal trial, the largest study of AID therapy in people with type 2 diabetes.
TUESDAY, July 2, 2024 -- Transgender and gender-diverse individuals have a higher risk for experiencing all forms of violence compared with cisgender...